Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
This special issue is devoted to darbepoetin alfa, a novel erythropoiesis stimulating protein (NESP), and includes articles describing its preclinical development, as well as preliminary data from clinical trials of NESP in patients with cancer.